The Seattle-based biotech company aims to make new drug discovery faster and cheaper by using AI to simulate the results from ...

Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop tomorrows genetic therapies.

PlantArcBio (TASE: PLNT) is pleased to announce that it has been granted patents in the United States and South Korea for its proprietary DIPPER™ platform, a breakthrough technology designed to ...

A gene-editing tool that can turn genes on and off like a light switch has been developed. Turning a gene on means activating ...

Krystal Biotech reports positive clinical data for KB408 and KB407, demonstrating safety and efficacy in AATD and cystic fibrosis patients. Krystal Biotech, Inc. has announced promising clinical ...

Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are actively expressed at any given time in a cell determines what type of cell it ...

Our models help scientists predict the results of new and currently impossible experiments to move their science forward much ...

Single cell gene expression studies often rely on single-cell RNA sequencing (scRNA-seq) alone. While scRNA-seq reveals which genes are turned on, it does not capture protein expression or changes to ...

Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question, dubbed ...

Scientists edited grape cells with CRISPR to boost resveratrol output, offering a cleaner and more sustainable alternative to ...